Cullinan Therapeutics, Inc. (CGEM) Discusses Initial CLN-049 Results and Development Strategy for AML Applications Transcript

Cullinan Therapeutics, Inc. (CGEM) Discusses Initial CLN-049 Results and Development Strategy for AML Applications Transcript#Cullinan #Therapeutics #CGEM #Discusses #Initial #CLN049 #Results #Development #Strategy #AML #Applications #Transcript